Form 4: Adicet Bio CFO Acquires Stock Options
SEC Form 4 Filing
Adicet Bio's Chief Financial Officer, Brian Nicholas Harvey, acquired stock options for 374,829 shares of common stock on June 5, 2024.
Summary
- Brian Nicholas Harvey, the Chief Financial Officer of Adicet Bio, Inc., filed a Form 4 on June 7, 2024.
- The filing reports a transaction on June 5, 2024, where Harvey acquired stock options for 374,829 shares of Adicet Bio's common stock at an exercise price of $2.53.
- These options vest in equal monthly installments over 48 months, starting January 26, 2024, contingent upon continued service with the company.
- Following the transaction, Harvey directly owns options for 374,829 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which can be interpreted as a sign of confidence, but it doesn't inherently suggest a positive or negative outlook.
Positives
- The acquisition of stock options by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Stakeholder Impact
- Shareholders may view the CFO's stock option acquisition as a positive signal, aligning management's interests with theirs.
Key Dates
| Date | Description |
|---|---|
| January 26, 2024 | Vesting start date for the stock options. |
| June 05, 2024 | Date of the stock option acquisition. |
| June 07, 2024 | Date the Form 4 was filed. |
| January 25, 2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.